INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 41 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $229,000 | -7.7% | 52,792 | +55.9% | 0.10% | -10.2% |
| Q1 2019 | $248,000 | +342.9% | 33,869 | +165.5% | 0.11% | +730.8% |
| Q2 2018 | $56,000 | -67.3% | 12,759 | -52.7% | 0.01% | -63.9% |
| Q1 2018 | $171,000 | +119.2% | 26,959 | +77.0% | 0.04% | +140.0% |
| Q4 2017 | $78,000 | – | 15,232 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |